What does LA PHARMACIE DE VRIESE do?

LA PHARMACIE DE VRIESE is a pharmacy in Nivelles. Private Limited, started on 15 December 1987, 1 establishment.

What is the address of LA PHARMACIE DE VRIESE?

The registered office of LA PHARMACIE DE VRIESE is located at Place des Déportés 13, 1400 Nivelles.

Is LA PHARMACIE DE VRIESE still active?

Yes. According to the CBE (29 October 2026) LA PHARMACIE DE VRIESE is active, legal situation “Normale toestand”, started on 15 December 1987.

Is LA PHARMACIE DE VRIESE registered on Peppol?

Yes, LA PHARMACIE DE VRIESE is registered on the Peppol network with ID 0208:0432814988.

What is the enterprise number of LA PHARMACIE DE VRIESE?

The enterprise number of LA PHARMACIE DE VRIESE is BE0432814988.

When was LA PHARMACIE DE VRIESE founded?

LA PHARMACIE DE VRIESE was founded on 15 December 1987.

Who are the directors of LA PHARMACIE DE VRIESE?

According to the 2025 annual accounts, the directors of LA PHARMACIE DE VRIESE are: ADV PHARMA SRL, CAROLINE DE VRIESE.

Is LA PHARMACIE DE VRIESE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 15 December 1987; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did LA PHARMACIE DE VRIESE make in 2025?

LA PHARMACIE DE VRIESE posted a profit after taxes of € 307,840 in financial year 2025.

What is the revenue of LA PHARMACIE DE VRIESE?

As a small company, LA PHARMACIE DE VRIESE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 831,424.

How much does an employee at LA PHARMACIE DE VRIESE earn?

The average wage cost per full-time employee at LA PHARMACIE DE VRIESE was € 64,900 in 2025: staff costs of € 369,798 for 5.7 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does LA PHARMACIE DE VRIESE have?

According to the 2025 annual accounts, LA PHARMACIE DE VRIESE has 5.7 full-time equivalents (FTE).

LA PHARMACIE DE VRIESE (Private Limited) - Nivelles

Dossier LA PHARMACIE DE VRIESE, printed on 29 October 2026 from databakkes.be/en/0432814988/la-pharmacie-de-vriese. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 53 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

LA PHARMACIE DE VRIESE from Nivelles, company number BE0432814988, closed financial year 2025 with a result of € 307,840 after tax. For that financial year LA PHARMACIE DE VRIESE recorded a gross margin of € 831,424 and equity of € 320,772. Compared with financial year 2024, the result moved from € 322,717 to € 307,840. The company is profitable. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on June 19, 2026.

What it is worth Growing

€ 320,772

▲ 3% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 307,840

▼ 5% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 327,584

▼ 40% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 300,000 paid out

97 % of the profit went to the shareholders, mostly to ADV Pharma (100 % of the shares). That is where the money ends up.

People and assets in 2025

Full-time equivalents

5.7

▲ 1 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 369,798

▲ 20% vs 2024

€ 64,900 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 29,732

▼ 38% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 6 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 216,857

▼ 16% vs 2024

€ 39,286 is repaid this year. At this pace the long-term loan is gone in ≈ 6 years.

Owed to suppliers

€ 243,617

▲ 33% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 64,013

▲ 6% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 852,515 Gross margin 2022: € 852,515 First fiscal year in the series	€ 885,471 Gross margin 2023: € 885,471 ▲ 4% vs 2022 (€ 852,515) Favourable step	€ 800,193 Gross margin 2024: € 800,193 ▼ 10% vs 2023 (€ 885,471) Unfavourable step	€ 831,424 Gross margin 2025: € 831,424 ▲ 4% vs 2024 (€ 800,193) Favourable step	▲ 4%
Profit after taxes	€ 359,305 Profit after taxes 2022: € 359,305 First fiscal year in the series	€ 355,534 Profit after taxes 2023: € 355,534 ▼ 1% vs 2022 (€ 359,305) Unfavourable step	€ 322,717 Profit after taxes 2024: € 322,717 ▼ 9% vs 2023 (€ 355,534) Unfavourable step	€ 307,840 Profit after taxes 2025: € 307,840 ▼ 5% vs 2024 (€ 322,717) Unfavourable step	▼ 5%
Equity	€ 314,681 Equity 2022: € 314,681 First fiscal year in the series	€ 290,215 Equity 2023: € 290,215 ▼ 8% vs 2022 (€ 314,681) Unfavourable step	€ 312,932 Equity 2024: € 312,932 ▲ 8% vs 2023 (€ 290,215) Favourable step	€ 320,772 Equity 2025: € 320,772 ▲ 3% vs 2024 (€ 312,932) Favourable step	▲ 3%
Total debts	€ 1,733,123 Total debts 2022: € 1,733,123 First fiscal year in the series	€ 1,608,219 Total debts 2023: € 1,608,219 ▼ 7% vs 2022 (€ 1,733,123) Favourable step	€ 1,730,737 Total debts 2024: € 1,730,737 ▲ 8% vs 2023 (€ 1,608,219) Unfavourable step	€ 1,526,529 Total debts 2025: € 1,526,529 ▼ 12% vs 2024 (€ 1,730,737) Favourable step	▼ 12%
Cash	€ 434,427 Cash 2022: € 434,427 First fiscal year in the series	€ 403,643 Cash 2023: € 403,643 ▼ 7% vs 2022 (€ 434,427) Unfavourable step	€ 548,162 Cash 2024: € 548,162 ▲ 36% vs 2023 (€ 403,643) Favourable step	€ 327,584 Cash 2025: € 327,584 ▼ 40% vs 2024 (€ 548,162) Unfavourable step	▼ 40%
Land & buildings	€ 820,954 Land & buildings 2022: € 820,954 First fiscal year in the series	€ 788,523 Land & buildings 2023: € 788,523 ▼ 4% vs 2022 (€ 820,954) Unchanged	€ 756,092 Land & buildings 2024: € 756,092 ▼ 4% vs 2023 (€ 788,523) Unchanged	€ 725,138 Land & buildings 2025: € 725,138 ▼ 4% vs 2024 (€ 756,092) Unchanged	▼ 4%
Retained profit	€ 159,181 Retained profit 2022: € 159,181 First fiscal year in the series	€ 134,715 Retained profit 2023: € 134,715 ▼ 15% vs 2022 (€ 159,181) Unfavourable step	€ 157,432 Retained profit 2024: € 157,432 ▲ 17% vs 2023 (€ 134,715) Favourable step	€ 165,272 Retained profit 2025: € 165,272 ▲ 5% vs 2024 (€ 157,432) Favourable step	▲ 5%
Dividend	€ 410,000 Dividend 2022: € 410,000 First fiscal year in the series	€ 380,000 Dividend 2023: € 380,000 ▼ 7% vs 2022 (€ 410,000) Unchanged	€ 300,000 Dividend 2024: € 300,000 ▼ 21% vs 2023 (€ 380,000) Unchanged	€ 300,000 Dividend 2025: € 300,000 Unchanged (€ 300,000) Unchanged
Bank debt	€ 358,913 Bank debt 2022: € 358,913 First fiscal year in the series	€ 311,790 Bank debt 2023: € 311,790 ▼ 13% vs 2022 (€ 358,913) Favourable step	€ 257,707 Bank debt 2024: € 257,707 ▼ 17% vs 2023 (€ 311,790) Favourable step	€ 216,857 Bank debt 2025: € 216,857 ▼ 16% vs 2024 (€ 257,707) Favourable step	▼ 16%
Balance sheet total	€ 2,047,804 Balance sheet total 2022: € 2,047,804 First fiscal year in the series	€ 1,898,434 Balance sheet total 2023: € 1,898,434 ▼ 7% vs 2022 (€ 2,047,804) Unchanged	€ 2,043,669 Balance sheet total 2024: € 2,043,669 ▲ 8% vs 2023 (€ 1,898,434) Unchanged	€ 1,847,301 Balance sheet total 2025: € 1,847,301 ▼ 10% vs 2024 (€ 2,043,669) Unchanged	▼ 10%
Employees (FTE)	6.1 Employees (FTE) 2022: 6.1 First fiscal year in the series	6 Employees (FTE) 2023: 6 ▼ 0.1 vs 2022 (6.1) Unchanged	4.7 Employees (FTE) 2024: 4.7 ▼ 1.3 vs 2023 (6) Unchanged	5.7 Employees (FTE) 2025: 5.7 ▲ 1 vs 2024 (4.7) Unchanged	▲ 1

Key figures of LA PHARMACIE DE VRIESE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to LA PHARMACIE DE VRIESE?

What happened at LA PHARMACIE DE VRIESE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 19, 2026 New annual accounts for financial year 2025: profit of € 307,840 (▼ 5% vs 2024). Source: NBB ↗
2013 ADV PHARMA SRL became a director. NBB
2013 CAROLINE DE VRIESE became a director. NBB
Dec 30, 1987 New establishment in Nivelles. KBO
Dec 15, 1987 Start of the company according to the CBE. KBO

In short

From € 359,305 profit in 2022 to € 307,840 profit in 2025.

Paid € 256,231 in corporate taxes since 2022.

Best year ever: 2022, with € 359,305 profit.

On average € 145,900 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

ADV Pharma 100%

The stake of ADV Pharma comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

LA PHARMACIE DE VRIESE

Behind LA PHARMACIE DE VRIESE are ADV PHARMA SRL and CAROLINE DE VRIESE. The shares are held by ADV Pharma (100%).

Directors

According to the 2025 annual accounts

ADV PHARMA SRL

Manager · represented by ALINE DE VRIESE

Also active at: MEDI - PREST, La Pharmacie de Saintes, BAUPHAR

since 2013

CAROLINE DE VRIESE

Manager

Also active at: MEDI - PREST, ADV Pharma, La Pharmacie de Saintes, BAUPHAR

since 2013

Shareholders

ADV Pharma

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Place des Déportés 13

1400 Nivelles

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0432.814.988

VAT number

BE 0432.814.988

Registered office

Place des Déportés 13, 1400 Nivelles

Names & denominations

LA PHARMACIE DE VRIESE

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

15 December 1987

Peppol

Active · Active since 10 Dec 2025

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

LA PHARMACIE DE VRIESE

Warning lights

Financials

What happened to LA PHARMACIE DE VRIESE?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Details

Frequently asked questions